Sponsor or institution

Clinical trials and research at H. Lee Moffitt Cancer Center and Research Institute

• 70Clinical trials
• 1New in 30 days
• 3Countries

Newest trials

All recruiting trials (70)

• Melanoma treatment with immunotherapy guided by serial ctDNA testing

  This trial tests whether regular ctDNA blood tests during treatment can help tailor the plan for patients with advanced melanoma receiving nivolumab and ipilimumab.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT07930182

• Domatinostat with Sirolimus for relapsed or refractory sarcoma and osteosarcoma

  This study tests whether the cancer drugs domatinostat and sirolimus together can help adolescents and adults whose sarcoma or osteosarcoma has come back or stopped responding to standard therapy.

  Recruiting at 2 sites Phase 1/2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida and 3 other locations · NCT07725380

• Dendritic Cell Vaccine with HER2-targeted Therapy or Nivolumab for Breast Cancer with Leptomeningeal Metastasis

  This trial tests a dendritic cell vaccine added to trastuzumab for Her2-positive disease or to nivolumab for Her2-negative disease to see if it can be given safely to people with breast cancer that has spread to the leptomeninges.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT07694986

• See if SAVI Scout MD helps surgeons localize breast cancer more precisely

  This study tests whether the SAVI Scout MD radar reflectors help surgeons find and remove breast cancer more accurately, potentially reducing the need for a second operation.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT07686250

• PIPAC with Mitomycin C for unresectable peritoneal cancer

  This phase 1 study tests a breathy, pressurized chemotherapy method (PIPAC-MMC) to see if it is safe and tolerable for adults with unresectable peritoneal carcinomatosis from colorectal, appendiceal, or small bowel cancers.

  Recruiting Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT07487168

• High-dose testosterone followed by PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer

  This trial tests whether short-term high-dose testosterone followed by a PSMA-targeted radioligand (PSMA-617) can help men with metastatic castration-resistant prostate cancer that is progressing on castrate-level testosterone.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT07476001

• Mindfulness Relapse Prevention for Smoking and Alcohol in Cancer Survivors

  This study tests whether Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) helps cancer survivors quit smoking and reduce risky drinking compared with standard care.

  Recruiting H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT07447635

• Brain MRI checks every 6 months for people with stage IV breast cancer

  This phase III trial tests whether routine brain MRI every six months helps detect brain metastases earlier in adults with stage IV breast cancer who have no brain symptoms.

  Recruiting Phase 3 H. Lee Moffitt Cancer Center and Research Institute · Miami, Florida and 1 other locations · NCT07357298

• Melphalan liver perfusion followed by tebentafusp for metastatic uveal melanoma

  This Phase 2 trial tests whether melphalan delivered to the liver by percutaneous hepatic perfusion followed by tebentafusp helps people with HLA-A*02:01-positive metastatic uveal melanoma confined to the liver.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT07276386

• Asciminib maintenance after alloHCT or CAR T for adults with Ph+ ALL

  Doctors will try asciminib in adults with Ph+ ALL who are in remission after an allogeneic stem cell transplant or CAR T therapy to check safety and find the best dose to help prevent relapse.

  Recruiting Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT07250087

• First-in-human testing of FID-022 in solid tumor patients

  This project will test an AI tool to spot early cancer-related weight loss and see if diet and exercise support are acceptable for people with newly diagnosed pancreatic cancer.

  Recruiting H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT07249775

• Integrating personalized skin cancer risk feedback into community health centers

  This project tests whether giving adult patients personalized skin cancer risk information based on genetics and recent sun behaviors increases use of sun-protection and prevention activities at Tampa Family Health Centers.

  Recruiting H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida and 1 other locations · NCT07222995

• Intensive, sequenced chemotherapy for metastatic Ewing sarcoma

  This tests an upfront intense 'first strike' followed by sequential 'second strikes' and prolonged maintenance chemotherapy to try to cure people with newly diagnosed widely metastatic Ewing sarcoma or metastatic CIC‑rearranged sarcoma.

  Recruiting at 16 sites Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Birmingham, Alabama and 20 other locations · NCT07194044

• Ropeginterferon treatment for cutaneous T‑cell lymphoma

  This trial tests whether ropeginterferon-alfa-2b helps people with cutaneous T‑cell lymphoma who have not responded adequately to multiple prior skin-directed therapies.

  Recruiting Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT07047885

• Quality of life and symptom changes over two years in adults with CLL or SLL starting targeted therapy

  This study will see how quality of life, fatigue, and symptoms change over two years for adults with CLL or SLL who start treatment with a BTK inhibitor versus a BCL2 inhibitor.

  Recruiting H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT07030400

• MIND diet to improve thinking and memory after breast cancer

  This trial will try the MIND diet with breast cancer survivors who finished adjuvant treatment 6 months to three years ago and report thinking or memory problems and a low MIND diet score to see if it helps compared with usual diet.

  Recruiting H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT07018986

• Pembrolizumab for advanced cutaneous sarcomas (excluding angiosarcoma)

  This will try pembrolizumab every three weeks in adults with advanced or metastatic skin-based sarcomas that are not angiosarcoma.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida and 2 other locations · NCT07007273

• Using HDAC inhibition to enhance immunotherapy response in bladder cancer

  This study is testing a new combination treatment for patients with muscle invasive bladder cancer who can't take certain chemotherapy, to see if it helps improve their outcomes before surgery.

  Recruiting Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06963346

• CD40L-augmented tumor-infiltrating lymphocyte (TIL) therapy for advanced melanoma

  This trial will test a single infusion of CD40L-augmented tumor-infiltrating lymphocytes after chemotherapy in people with advanced or metastatic melanoma who have progressed on standard treatments.

  Recruiting Phase 1/2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06961357

• Elranatamab treatment after cilta-cel for high-risk relapsed myeloma patients

  This study is testing if Elranatamab can help high-risk myeloma patients who have already had cilta-cel live longer without their disease getting worse.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06947083

• Screening for metastasis in node-positive breast cancer after treatment

  This study is testing how often breast cancer spreads to other parts of the body in patients who have had chemotherapy and surgery, by using CT scans to check for any signs of metastasis.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06833502

• Using Tafasitamab and Lenalidomide for Large B-cell Lymphoma after CAR-T Therapy

  This study is testing if the combination of tafasitamab and lenalidomide can help people with Large B-cell Lymphoma who still have cancer after CAR-T therapy.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06760156

• Education and screening for colorectal cancer and hepatitis C

  This study is trying to see if educating patients aged 45-75 about colorectal cancer and hepatitis C can help them get screened for these conditions more often.

  Recruiting H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06745895

• Assessing treatment outcomes of Pembrolizumab in Black patients with advanced lung cancer

  This study is testing if a combination of chemotherapy and Pembrolizumab can help Black patients with advanced lung cancer who haven't been treated before.

  Recruiting at 11 sites Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida and 10 other locations · NCT06745882

• Using digoxin to treat relapsed medulloblastoma in young patients

  This study is testing if digoxin can help young patients with relapsed medulloblastoma feel better when other treatments have not worked.

  Recruiting at 17 sites Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Birmingham, Alabama and 17 other locations · NCT06701812

• Combining CLAG-M therapy with venetoclax for relapsed or refractory acute myeloid leukemia

  This study is testing if adding a drug called venetoclax to a standard treatment for relapsed or refractory acute myeloid leukemia can help patients feel better and live longer.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida and 1 other locations · NCT06660368

• Comparing Ruxolitinib and Prednisone for treating chronic GVHD

  This study is testing whether Ruxolitinib works better than Prednisone for adults with chronic graft-versus-host disease who need treatment.

  Recruiting at 6 sites Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Miami, Florida and 5 other locations · NCT06660355

• Combining ACR-368 and low dose gemcitabine for treating advanced head and neck cancer

  This study is testing if combining ACR-368 with a low dose of gemcitabine can help people with advanced head and neck cancer feel better and live longer.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06597565

• Increasing enrollment of Black and Hispanic patients in cancer clinical trials

  This study is trying to see if targeted outreach and support can help more Black and Hispanic patients join cancer clinical trials at Moffitt Cancer Center.

  Recruiting H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06560398

• Treatment with Enfortumab Vedotin for Advanced Colorectal and Liver Cancer

  This study is testing if a new drug called enfortumab vedotin can help adults with advanced colorectal or liver cancer who haven’t had success with other treatments.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06553885

• Combination of Pirtobrutinib and Brexucabtagene Autoleucel for Relapsed Mantle Cell Lymphoma

  This study is testing if combining two treatments, Pirtobrutinib and Brexucabtagene Autoleucel, can help people with relapsed mantle cell lymphoma feel better and improve their outcomes.

  Recruiting at 2 sites Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Stanford, California and 2 other locations · NCT06553872

• Stopping chemotherapy for patients with Acute Myeloid Leukemia after successful treatment

  This study is testing if adults with Acute Myeloid Leukemia who are in complete remission can safely stop their treatment after one year without the cancer coming back.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06511882

• Support program for patients with gastroesophageal cancer

  This study tests if a special support program with nutrition help can improve the health of patients with gastroesophageal cancer compared to regular care during their treatment.

  Recruiting at 2 sites H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida and 1 other locations · NCT06497569

• Personalized vaccine for high-risk triple negative breast cancer after chemotherapy

  This study is testing a personalized vaccine made from a patient's own immune cells to see if it can help people with high-risk triple negative breast cancer fight any leftover cancer after chemotherapy.

  Recruiting Early Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06435351

• Exercise program for patients with esophageal cancer before surgery

  This study tests whether a structured exercise program can help patients with esophageal cancer get stronger and healthier before their surgery to improve their recovery.

  Recruiting H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06430346

• Exercise and nutrition program for pancreatic cancer patients

  This study is testing a program that combines exercise and nutrition advice for pancreatic cancer patients to see if it helps them get healthier before surgery.

  Recruiting H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06423963

• A program to develop new treatment strategies for pediatric cancer patients with limited options

  This study is testing a new program that brings together experts to find better treatment options for kids with cancer who have few choices left.

  Recruiting at 5 sites H. Lee Moffitt Cancer Center and Research Institute · Hartford, Connecticut and 4 other locations · NCT06423950

• New treatment approach for metastatic breast cancer using existing drugs

  This study is testing a new way to use existing cancer drugs in a specific order to see if it can help women with hormone-positive, HER2-negative metastatic breast cancer who have already tried other treatments.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06409390

• Combining rituximab and zanubrutinib for treating indolent B-cell lymphomas

  This study is testing if combining two medications, rituximab and zanubrutinib, can help people with untreated indolent B-cell lymphomas feel better and improve their treatment outcomes.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06350318

• Combining avapritinib and decitabine for treating systemic mastocytosis with associated hematologic neoplasm

  This study is testing a new combination treatment of avapritinib and decitabine to see if it can help people with systemic mastocytosis and related blood cancers feel better and manage their condition more effectively.

  Recruiting at 2 sites Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Phoenix, Arizona and 6 other locations · NCT06327685

• Using biomarkers to detect early HPV-related throat cancer

  This study is testing a new way to use DNA and gene markers to see if they can help find early signs of throat cancer linked to HPV in newly diagnosed patients.

  Recruiting at 3 sites H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida and 2 other locations · NCT06305676

• Neoadjuvant and adjuvant immunotherapy for advanced melanoma

  This study is testing if a new type of immunotherapy can help people with advanced melanoma do better before and after surgery.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06295159

• Combining Sacituzumab Govitecan and Zimberelimab with Stereotactic Radiation for Metastatic Triple Negative Breast Cancer with Brain Metastases

  This study is testing if combining two treatments, Sacituzumab Govitecan and Zimberelimab, with targeted radiation can help adults with metastatic triple negative breast cancer that has spread to the brain feel better compared to just using Sacituzumab Govitecan alone.

  Recruiting Phase 1/2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06238921

• Using modified T cells to target prostate cancer cells

  This study is testing a new treatment using modified T cells to see if it can help men with advanced prostate cancer who have run out of other options.

  Recruiting Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06193486

• Treatment for B-Cell Acute Lymphoblastic Leukemia with KTE-X19

  This study is testing if a new CAR T-cell therapy called KTE-X19 can help adults with B-Cell Acute Lymphoblastic Leukemia who are in remission but still have some leftover cancer cells.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06144606

• Personalized radiation therapy for head and neck cancer

  This study is testing whether using MRI to tailor radiation therapy can improve treatment for people with head and neck cancer.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06137274

• Combining Cemiplimab and Ziv-Aflibercept for Metastatic Uveal Melanoma

  This study is testing if the combination of Cemiplimab and Ziv-Aflibercept can help shrink tumors or stop their growth in people with metastatic uveal melanoma who have already tried other treatments.

  Recruiting at 4 sites Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Los Angeles, California and 3 other locations · NCT06121180

• Ablative radiation before CAR-T therapy for high-risk lymphoma

  This study is testing if giving radiation therapy before CAR T-cell treatment can help people with high-risk lymphoma have better results.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06104592

• Tumor-infiltrating lymphocyte therapy for children and young adults with high-risk solid tumors

  This will test whether doctors can grow a child’s own tumor‑infiltrating lymphocytes and safely give them back with chemotherapy and interleukin‑2 to treat high‑risk pediatric solid tumors.

  Recruiting Phase 1 H. Lee Moffitt Cancer Center and Research Institute · St. Petersburg, Florida · NCT06047977

• Increasing cancer awareness and education in Hispanic communities

  This study is trying to see if educational programs and community forums can help Hispanic communities learn more about cancer and reduce health disparities.

  Recruiting at 2 sites H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida and 1 other locations · NCT05832177

• Using itacitinib to improve CAR T cell therapy outcomes in lymphoma patients

  This study is testing if taking itacitinib before and after CAR T cell therapy can help improve outcomes for lymphoma patients with high inflammation levels.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT05757219

• Helping Cambodian people with HIV quit smoking using text messages

  This study is testing if sending text messages can help people in Cambodia who have HIV quit smoking by providing support and resources.

  Recruiting at 3 sites H. Lee Moffitt Cancer Center and Research Institute · Phnom Penh and 2 other locations · NCT05746442

• Using enhanced immune cells to treat specific types of lung cancer

  This study is testing a new treatment using special immune cells and a drug to see if it can help people with advanced lung cancer that has certain genetic changes and hasn’t improved with previous treatments.

  Recruiting Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT05681780

• Evaluating biomarkers for diagnosing and monitoring lung cancer

  This study is testing if certain blood and tissue markers can help doctors better diagnose lung cancer and identify patients at risk for recurrence after surgery.

  Recruiting H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT05665504

• Comparing different dosing schedules of Vismodegib for advanced skin cancer

  This study is testing different ways to take Vismodegib to see which schedule works best for adults with advanced skin cancer.

  Recruiting Early Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT05651828

• CalPeg treatment for newly diagnosed acute lymphoblastic leukemia

  This study is testing if adding a new treatment called calaspargase pegol to standard chemotherapy helps people with newly diagnosed acute lymphoblastic leukemia feel better and have fewer side effects.

  Recruiting Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT05581030

• Combining CPX-351 with Gemtuzumab Ozogamicin for Newly Diagnosed AML

  This study is testing a combination of two treatments, CPX-351 and gemtuzumab ozogamicin, to see if they are safe and effective for adults with newly diagnosed acute myeloid leukemia (AML).

  Recruiting Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT05558124

• Genomically guided radiation therapy for triple negative breast cancer

  This study is testing if personalized radiation therapy based on the genetic makeup of triple negative breast cancer can improve treatment for patients who have had breast-conserving surgery.

  Recruiting at 2 sites Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Clearwater, Florida and 1 other locations · NCT05528133

• Combining dostarlimab and niraparib for advanced penile cancer

  This study is testing if a new combination of two drugs, dostarlimab and niraparib, can help people with advanced penile cancer who haven't had success with other treatments.

  Recruiting at 2 sites Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida and 1 other locations · NCT05526989

• DC1 dendritic-cell vaccine with chemotherapy for early-stage triple-negative and ER-low breast cancer

  This trial will test whether a dendritic cell vaccine given with standard chemotherapy helps people with early-stage triple-negative or ER-low breast cancer.

  Recruiting Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT05504707

• HER2-targeted vaccine combined with standard chemotherapy for breast cancer

  This study is testing if adding a new vaccine to standard chemotherapy can help people with HER2-positive breast cancer have better treatment results.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT05325632

• Infusion of modified T cells to target ovarian cancer

  This study is testing a new treatment using modified immune cells to see if they can safely help people with recurring ovarian cancer.

  Recruiting Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT05316129

• Using advanced radiation therapy for high-grade soft tissue sarcoma treatment

  This study is testing a new way of using advanced radiation therapy to treat high-grade soft tissue sarcoma by targeting specific areas of the tumor to improve treatment while protecting healthy tissue.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT05301283

• Screening brain MRIs for patients with stage IV breast cancer

  This study tests if regular brain MRI scans can help find hidden issues in the brains of patients with stage IV breast cancer who don’t have any symptoms yet.

  Recruiting Phase 2 H. Lee Moffitt Cancer Center and Research Institute · Clearwater, Florida and 1 other locations · NCT05115474

• Combining Vyxeos and Gilteritinib for FLT3-Mutated Acute Myeloid Leukemia

  This study is testing if combining two drugs, vyxeos and gilteritinib, can help people with FLT3-mutated acute myeloid leukemia who have not responded to previous treatments.

  Recruiting Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT05024552

• Using Cemiplimab before surgery for skin cancers

  This study is testing if giving a new immunotherapy drug before surgery can help people with certain types of skin cancer have better outcomes.

  Recruiting Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT04975152

• Combining Stereotactic Radiation with Abemaciclib for Breast Cancer Brain Metastases

  This study is testing if combining a medication called abemaciclib with targeted radiation can help people with hormone receptor-positive breast cancer that has spread to the brain live longer without their cancer getting worse.

  Recruiting Phase 1/2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida and 1 other locations · NCT04923542

• Adjuvant therapy for melanoma based on treatment response

  This study tests if a combination of new medications can help people with melanoma who have a specific gene mutation stay cancer-free after their initial treatment.

  Recruiting Early Phase 1 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT04741997

• Developing new treatment strategies for patients with incurable diseases

  This study is testing a new team approach to see if personalized treatment plans from a special group can help patients with incurable diseases feel better and improve their care.

  Recruiting H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT04343365

• Using PSMA-PET imaging to find early metastatic prostate cancer in men with high Decipher test scores

  This study is testing a new type of imaging to see if it can help find early signs of recurring prostate cancer in men with high-risk test scores.

  Recruiting Phase 2/3 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT03495427

Quick answers

How many clinical trials run by H. Lee Moffitt Cancer Center and Research Institute are recruiting right now?

70, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (69 trials), Cambodia (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 30, Phase 1: 15, Phase 1/2: 4, Early Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →